Valuation: Edwards Lifesciences Corporation

Capitalization 44.43B 37.71B 34.53B 32.56B 60.73B 4,233B 61.22B 410B 160B 2,016B 167B 163B 6,977B P/E ratio 2026 *
27.4x
P/E ratio 2027 * 23.6x
Enterprise value 40.92B 34.73B 31.8B 29.99B 55.93B 3,899B 56.38B 377B 147B 1,857B 154B 150B 6,426B EV / Sales 2026 *
6.07x
EV / Sales 2027 * 5.31x
Free-Float
87.24%
Yield 2026 *
-
Yield 2027 * -
1 day-3.49%
1 week-7.39%
Current month-7.58%
1 month-0.90%
3 months-2.72%
6 months-9.38%
Current year-9.48%
1 week 76.49
Extreme 76.49
84.42
1 month 76.49
Extreme 76.49
85.06
Current year 74.66
Extreme 74.66
87.32
1 year 72.3
Extreme 72.3
87.89
3 years 58.93
Extreme 58.93
96.12
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 59 2013-12-31
Chief Tech/Sci/R&D Officer - 2019-01-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Change 5d. change 1-year change 3-years change Capi.($)
-3.49%-7.39%+4.74%-13.08% 44.43B
-2.67%-2.16%+12.27%-14.57% 168B
-6.67%-7.14%-21.71%+38.42% 149B
-2.71%-4.32%-12.23%-27.85% 118B
-1.04%-6.12%-48.11%-0.04% 79.33B
+0.76%-3.78%-30.58%-37.00% 44.14B
-1.99%+15.30%+1.17%+29.41% 34.17B
-3.60%-0.64%+4.24%-12.69% 31.5B
-0.82%+0.48%-24.46%-44.35% 30.12B
-3.87%-5.09%-18.89%-15.82% 28.83B
Average -1.89%-0.86%-13.36%-9.76% 72.73B
Weighted average by Cap. -1.66%-2.70%-11.92%-4.70%

Financials

2026 *2027 *
Net sales 6.75B 5.73B 5.24B 4.94B 9.22B 643B 9.3B 62.19B 24.27B 306B 25.32B 24.78B 1,060B 7.41B 6.29B 5.76B 5.43B 10.13B 706B 10.21B 68.28B 26.65B 336B 27.8B 27.21B 1,163B
Net income 1.64B 1.39B 1.27B 1.2B 2.24B 156B 2.25B 15.08B 5.88B 74.22B 6.14B 6.01B 257B 1.89B 1.6B 1.47B 1.39B 2.58B 180B 2.61B 17.43B 6.8B 85.81B 7.1B 6.95B 297B
Net Debt -3.51B -2.98B -2.73B -2.57B -4.8B -334B -4.84B -32.35B -12.63B -159B -13.17B -12.89B -551B -5.13B -4.35B -3.99B -3.76B -7.01B -489B -7.07B -47.26B -18.45B -233B -19.24B -18.84B -805B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-05-11 77.17 $ -3.49% 5,262,032
26-05-08 79.96 $ -3.38% 4,031,273
26-05-07 82.76 $ -0.53% 3,332,532
26-05-06 83.20 $ +0.35% 5,083,742
26-05-05 82.91 $ -0.50% 3,288,318
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
77.17USD
Average target price
97.15USD
Spread / Average Target
+25.89%

Quarterly revenue - Rate of surprise